Up First from NPR CDC Vaccine Vote; Netflix Buys Warner Bros; Economic Outlook
128 snips
Dec 6, 2025 
Rob Stein, an NPR health correspondent, discusses the CDC advisory committee's controversial recommendation to delay hepatitis B vaccines for newborns, potentially reversing decades of progress in combating the disease. Mandalit Delbarco, a culture correspondent, dives into Netflix's blockbuster $83 billion acquisition of Warner Bros., exploring the impact on Hollywood and concerns over antitrust issues. Scott Horsley, an economics correspondent, analyzes consumer sentiment trends and the Federal Reserve's complex decisions about interest rates amid ongoing inflation.
AI Snips
Chapters
Transcript
Episode notes
Roll Back Of Newborn Hep B Policy
- The CDC advisory committee voted to delay routine newborn hepatitis B vaccination, reversing a 30-year policy that cut infections dramatically.
- Public health experts warn this change could undo decades of progress and increase chronic liver disease risk.
Committee Skepticism Linked To Leadership Changes
- Some new committee members question the necessity and safety of giving hepatitis B shots to newborns so early.
- That skepticism stems from appointments by Health and Human Services Secretary Robert F. Kennedy Jr., who opposes vaccines.
Who Should Still Get The Birth Dose
- Babies born to mothers positive or with unknown hepatitis B status should still get the vaccine at birth.
- Parents of babies with mothers who test negative should consult their pediatrician about timing.